Sci­en­tists alarmed about fu­ture of can­cer re­search; TIG­IT, CAR-NK and more from #AACR25

Last month
R&D

The End­points Slack in­ter­view: Arc In­sti­tute's Patrick Hsu on in­vest­ing, AI and new ways of re­search

Last month
People
AI

Im­mu­nic’s stock falls on mul­ti­ple scle­ro­sis da­ta; En­tra­da’s lay­offs

Last month
News Briefing

FDA ap­proves J&J's rare dis­ease drug that's ex­pect­ed to com­pete with ar­genx and UCB

Last month
Pharma
FDA+

Up­dat­ed: No­var­tis to buy Reg­u­lus Ther­a­peu­tics for up to $1.7B

Last month
Deals
Pharma

GSK's sup­ply chain 're­set' af­ter Ha­le­on spin­off to ease tar­iff im­pact, CEO says

Last month
Pharma
Manufacturing

Bridge­Bio’s At­tru­by out­per­forms sales ex­pec­ta­tions, shares rise

Last month
Pharma

Ex­clu­sive: No­ma Ther­a­py rais­es $4M for vir­tu­al ke­t­a­mine-as­sist­ed ther­a­py

Last month
Financing
Health Tech

Ar­tios drug ex­ploits ‘repli­ca­tion stress’ in can­cer, shrink­ing sub­set of tu­mors in ear­ly study

Last month
Startups
R&D

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Last month
China
Pharma

Join us at 12 p.m. ET: How phar­ma is re­act­ing to ‘Lib­er­a­tion Day’

Last month
Editor's note
Pharma

In­side De­vot­ed Health’s 2024 fi­nan­cials

Last month
Health Tech

Mer­ck plans to bring Keytru­da pro­duc­tion to the US with $1B bi­o­log­ics fac­to­ry

Last month
Manufacturing

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Last month
Pharma
Cell/Gene Tx

FDA won't re­or­ga­nize med­ical prod­uct cen­ters, Makary says in in­ter­view: 'I re­ject­ed that pro­pos­al'

Last month
FDA+

Ab­b­Vie’s Rin­voq is ap­proved in gi­ant cell ar­teri­tis; Rel­ma­da shares blad­der can­cer da­ta

Last month
News Briefing

With a new CEO, oligonu­cleotide biotech Crey­on forges Eli Lil­ly part­ner­ship

Last month
Financing
Startups

De­vot­ed Health shrank its op­er­at­ing loss­es in 2024 as rev­enue ex­plod­ed

Last month
Startups
Health Tech

Hims and No­vo Nordisk part­ner to of­fer dis­count­ed We­govy

Last month
Pharma
Health Tech

As­traZeneca, No­var­tis ex­e­cute ‘US for US’ strat­e­gy as phar­ma tar­iffs near

Last month
China
Pharma

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

Last month
Pharma

Ex­clu­sive: Basil Sys­tems rais­es $11.5M to help phar­ma nav­i­gate reg­u­la­tions

Last month
Financing
Health Tech

As­traZeneca posts an­oth­er Truqap study fail, says Chi­na im­port tax could triple

Last month
China
Pharma

No­var­tis con­tin­ues earn­ings win­ning streak as it rais­es 2025 sales ex­pec­ta­tions

Last month
R&D
Pharma
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times